AzTrials
AzTrials

Cervical Radicular PainNCT07054450

Assessment and Rehabilitation in Cervical Radiculopathy

A study testing All patients in the study will be included in rehabilitation program and Study Group will receive a nutraceutical product daily, 3 months. in people with Cervical Radicular Pain and Spondyloarthritis (SA), run by Filantropia Hospital at 1 site in Romania.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The investigators perform a prospective controlled study and analyse the effects of a rehabilitation program, including oral anti-inflammatory drugs, nutraceutical - ProHumano+ SpineDinamic (PHSD), physical therapy and kinetic measures on reduction of the severity of radicular pain, and improvement of the quality of… Read more about this study

Who is it for?
Ages 50 to 79 years
What is being tested?
All patients in the study will be included in rehabilitation program and Study Group will receive a nutraceutical product daily, 3 months.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteRomania
Study dates
10 May 2025to 15 Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 79 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients older than 50 years of age;
  • lasting more than 3 months and diagnosed with CR confirmed by MRI in the last 6 months;
  • absence of other significant and disability upper limb osteoarthritis;
  • patients with stable cardiovascular and respiratory function, without unstable medical conditions;
  • compliance with physical exercise during the healthcare program.

Who cannot join

  • pregnancy or breastfeeding;
  • need for surgical treatment;
  • intolerance to any component of the nutraceutical product;
  • malignancy;
  • modified laboratory test (ALT, AST, or Urea >2x% reference range, Creatinine >3x% reference range).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Romania1 site
  • Diana Kamal

    Craiova, 1100

Other trials in Romania

About this study

Official title: Patient With Cervical Radiculopathy - Complete Assessment and Rehabilitation

The investigators perform a prospective controlled study and analyse the effects of a rehabilitation program, including oral anti-inflammatory drugs, nutraceutical - ProHumano+ SpineDinamic (PHSD), physical therapy and kinetic measures on reduction of the severity of radicular pain, and improvement of the quality of life in participants with cervical radiculopathy (CR) over a relatively short period of treatment (three months).

The major tasks in the assessment and management of CR are to exclude signs and/or symptoms of possible serious underlying pathology, to focus on an active approach to promote the natural recovery and to prevent chronicity through early tailored rehabilitation

Being tested
All patients in the study will be included in rehabilitation program, Study Group will receive a nutraceutical product daily, 3 months.
Keywords
cervical radiculopathy, physical medicine and rehabilitation, quality of life, nutraceutical treatment
Medical subject headings
Spondylarthritis, Radiculopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • All patients in the study will be included in rehabilitation programCombination product

    A total of 110 consecutive participants with previous diagnosed CR lasting more than 3 months will be enrolled in this study. After initial assessment, participants without surgical recommendation, will be included into two groups: Study Group will be received 10 sessions of rehabilitation program and nutraceutical product daily, 3 months, and Control Group will be received 10 sessions of rehabilitation program. The rehabilitation program include physical therapy (electrical muscle stimulation of the neck muscle and upper limb muscles , low-Level Laser Therapy and ultrasound) and kinetic training.

  • Study Group will receive a nutraceutical product daily, 3 months.Dietary supplement

    Study Group will receive a nutraceutical product daily, 3 months in addition to the rehabilitation program.

Study groups in NCT07054450
Study groupRoleWhat they receive
Study GroupExperimentalStudy Group will receive 10 sessions of rehabilitation program and nutraceutical product daily for 3 months.
Receives: Combination Product: All patients in the study will be included in rehabilitation program; Dietary Supplement: Study Group will receive a nutraceutical product daily, 3 months.
Control GroupActive comparatorControl Group will receive 10 sessions of rehabilitation program.
Receives: Combination Product: All patients in the study will be included in rehabilitation program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neck Disability Index

    Patient-completed, condition-specific functional status questionnaire with 10 items including pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. Score: /50 Transform to percentage score x 100 = %points Scoring: For each section the total possible score is 5: if the first statement is marked the section score = 0, if the last statement is marked it = 5. If all ten sections are completed the score is calculated Minimum Detectable Change (90% confidence): 5 points or 10 %points

    Measured: 3 months

  2. Visual Analogue Scale For Pain

    The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. Values close to 100 show a maximum value of pain, and 0 the absence of pain.

    Measured: 3 months

Secondary outcomes (1)
  1. Improving quality of life- Katz Index of Independence in Activities of Daily Living

    The Katz Index of Independence in Activities of Daily Living, commonly referred to as the Katz ADL, is the most appropriate instrument to assess functional status as a measurement of the participants ability to perform activities of daily living independently. Investigators typically use the tool to detect problems in performing activities of daily living and to plan care accordingly. The Index ranks adequacy of performance in the six functions of bathing, dressing, toileting, transferring, continence, and feeding. Participants are scored yes/no for independence in each of the six functions. A score of 6 indicates full function, 4 indicates moderate impairment, and 2 or less indicates severe functional impairment.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2025
  2. Study start10 May 2025
  3. Primary completion14 May 2025
  4. Study completion15 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Study Group will be receiving a nutraceutical product daily, for 3 months,
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07054450
Sponsor's protocol ID
FilantropiaH
Status last verified
Jun 2025
First submitted
19 Jun 2025
Last updated
8 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing All patients in the study will be included in rehabilitation program and Study Group will receive a nutraceutical product daily, 3 months. in people with Cervical Radicular Pain and Spondyloarthritis (SA), run by Filantropia Hospital at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 8 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neck Disability Index (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in